Article | February 1, 2019

Cell Therapy: Process Design Considerations To Support Commercialization

Source: Integrated Project Services (IPS)

By Herman Bozenhardt, Bozenhardt Consulting Services, and Erich Bozenhardt, IPS-Integrated Project Services

Pall-iCELLis-Bioreactor

Cell therapies have the potential to revolutionize the biopharmaceutical world, but today’s processes, logistics, and delivery make for a challenging entry into the sector’s growth curve. As the industry evolves, we will have to answer (at least) three important questions when bringing these exciting new therapies to market.

Integrated Project Services (IPS)